Pages Menu
FacebookTwitterPinterestRss
Categories Menu

CTD Holdings

CTD Holdings


CTD HOLDINGS IV TRAPPSOL CYCLO STUDY

The NNPDF Central Office has received notice that
CTD’s US trial parameters for the IV Trappsol Cyclo study in NPC
are now published at Clinical Trials.Gov.


CTD HOLDINGS PRESS RELEASE

CTD Holdings Announces MHRA Approval of Clinical Trial
Application for Treatment of NPC With Trappsol(R) Cyclo(TM)

CLICK HERE FOR FULL RELEASE


09/29/2016 jjb